Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial

Paling, Fleur P; Olsen, Karina; Ohneberg, Kristin; Wolkewitz, Martin; Fowler, Vance G (Jr); DiNubile, Mark J; Jafri, Hasan S; Sifakis, Frangiscos; Bonten, Marc J M; Harbarth, Stéphan Juergen; Kluytmans, Jan A J W

Advanced search

Browse by...

Deposit

Highlights

More informations

Title		Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial
Authors		Paling, Fleur P Olsen, Karina Ohneberg, Kristin Wolkewitz, Martin Fowler, Vance G (Jr) DiNubile, Mark J Jafri, Hasan S Sifakis, Frangiscos Bonten, Marc J M Harbarth, Stéphan Juergen Kluytmans, Jan A J W show all authors [1 - 11]
Published in		PLOS ONE. 2018, vol. 13, no. 3, p. e0193445
Abstract		Identifying patients undergoing cardiothoracic surgery at high risk of Staphylococcus aureus surgical site infection (SSI) is a prerequisite for implementing effective preventive interventions. The objective of this study was to develop a risk prediction model for S. aureus SSI or bacteremia after cardiothoracic surgery based on pre-operative variables.
Keywords		Adult — Aged — Cardiovascular Surgical Procedures/adverse effects — Double-Blind Method — Female — Humans — Male — Middle Aged — Prospective Studies — Risk Factors — Staphylococcal Infections/diagnosis/microbiology/prevention & control — Staphylococcal Vaccines/therapeutic use — Staphylococcus aureus/pathogenicity — Surgical Wound Infection/diagnosis/microbiology/prevention & control — Vaccination
Identifiers		DOI: 10.1371/journal.pone.0193445 PMID: 29561866
Full text		Article (Published version) (1.4 MB) - Free access
Structures		Faculté de médecine / Section de médecine clinique / Département de médecine interne des spécialités
Research group		Groupe Harbarth Stephan (Staphylocoques dorés résistants à la méthicilline) (866)
Citation (ISO format)		PALING, Fleur P et al. Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial. In: PLOS ONE, 2018, vol. 13, n° 3, p. e0193445. https://archive-ouverte.unige.ch/unige:111007